Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Akeso HK$2.44 billion IPO
Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S…
Baidu $1 billion notes offering
Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $600 million 3.075% notes due 2025 and $400 million 3.425% notes due 2030. Baidu, Inc. is a…
InnoCare Pharma HK$2.24 billion IPO
Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
Tianfeng Securities $100 million notes offering
Davis Polk advised Tianfeng Securities Co., Ltd. in connection with its $100 million notes offering. The notes will be consolidated and form a single series with the $200 million notes…
Fujian Yango $110 million high-yield notes offering
Davis Polk advised the joint lead managers in connection with the Regulation S offering of $110 million principal amount of 12.5% senior notes due 2022 by Yango (Cayman) Investment Limited…
CITIC Capital Acquisition $276 million IPO
Davis Polk advised the sole underwriter in connection with the initial public offering of 27,600,000 units of CITIC Capital Acquisition Corp., including 3,600,000 units purchased pursuant…
Back to top